Q-Bank Breakdown: Paraneoplastic syndromes — Why Every Answer Choice Matters

Paraneoplastic syndromes are classic “Step traps” because the patient’s symptoms are real—but they’re not caused by local tumor invasion or metastasis. Instead, they’re mediated by ectopic hormone production or immune cross-reactivity, and question writers love to test whether you can separate “tumor effects” from “paraneoplastic effects” while also recognizing the single most likely underlying malignancy.

---

The Clinical Vignette (Q-bank style)

A 66-year-old man with a 50-pack-year smoking history comes to clinic for progressive fatigue and confusion. He has nausea and mild headache. Vitals are stable. Exam is notable for mild disorientation but no focal deficits. Labs show:

Chest X-ray reveals a central/hilar mass. He is clinically euvolemic.

Question: Which mechanism best explains this patient’s presentation?

A. Autoantibodies against presynaptic calcium channels in the neuromuscular junction
B. Ectopic secretion of ADH by a tumor
C. Increased renin secretion due to renal hypoperfusion from tumor compression
D. Tumor secretion of PTH-related peptide (PTHrP)
E. Ectopic secretion of insulin-like growth factor 2 (IGF-2)

---

Step Strategy: Define “Paraneoplastic” Before You Pick

A true paraneoplastic syndrome is:

• Remote effect of malignancy (not due to mass effect, invasion, or metastasis)
• Usually due to:
  • Ectopic hormone production (e.g., ADH, ACTH, PTHrP)
  • Immune-mediated phenomena (antibodies cross-reacting with normal tissue)

This vignette screams SIADH: hypotonic hyponatremia with inappropriately concentrated urine and high urine sodium in an euvolemic patient.

---

Correct Answer: B. Ectopic secretion of ADH by a tumor

Why it fits best

• Hyponatremia + low serum osmolality + high urine osmolality = ADH is “on” when it shouldn’t be
• High urine sodium in an euvolemic patient supports SIADH (the body dumps sodium to compensate for mild volume expansion)
• Central/hilar lung mass + heavy smoker strongly suggests small cell lung carcinoma (SCLC), the classic cause of ectopic ADH

High-yield SIADH pattern (USMLE-ready)

• Serum: low Na⁺, low osmolality
• Urine: inappropriately high osmolality, high sodium
• Volume status: typically euvolemic (no edema, no orthostasis)

Classic association

• Small cell lung carcinoma → SIADH (ADH) and Cushing syndrome (ACTH)

---

Now, Why Each Distractor Is Wrong (and what it would look like)

A. Autoantibodies against presynaptic calcium channels

This describes Lambert-Eaton myasthenic syndrome (LEMS).

What you’d expect instead:

• Proximal muscle weakness (legs > arms)
• Hyporeflexia that improves with repeated use
• Autonomic symptoms (dry mouth, erectile dysfunction)
• Often associated with small cell lung carcinoma

Why it’s wrong here: No neuromuscular symptoms; the stem is a pure electrolyte/osmolality problem.

---

C. Increased renin secretion due to renal hypoperfusion from tumor compression

This is not a classic paraneoplastic mechanism; it’s a secondary hyperaldosteronism concept from decreased renal perfusion (or renin-secreting tumors, which are rare and not the point of this vignette).

What you’d expect instead:

• Hypertension
• Hypokalemic metabolic alkalosis (from aldosterone effect)
• Elevated renin and aldosterone (if secondary)

Why it’s wrong here: The patient’s key abnormality is hyponatremia with concentrated urine, not hyperaldosterone physiology.

---

D. Tumor secretion of PTH-related peptide (PTHrP)

This is the classic mechanism of humoral hypercalcemia of malignancy.

Common tumor associations:

• Squamous cell carcinoma of the lung
• Squamous cell carcinomas elsewhere (head/neck, esophagus)
• Renal cell carcinoma, bladder, ovarian (varies by source, but squamous lung is the money association)

What you’d expect instead:

• Hypercalcemia symptoms: “stones, bones, groans, psychiatric overtones”
• Constipation, polyuria, abdominal pain, confusion
• Labs: high Ca²⁺, low PTH, often low phosphate

Why it’s wrong here: Sodium is low; the urine findings point to ADH excess, not calcium excess. Also the radiographic clue (central mass) favors SCLC more than squamous (classically central too, but the SIADH lab pattern is the giveaway).

---

E. Ectopic secretion of IGF-2

This points to non–islet cell tumor hypoglycemia, classically from mesenchymal tumors (e.g., solitary fibrous tumor) and some large tumors.

What you’d expect instead:

• Episodic neuroglycopenic symptoms: sweating, tremor, confusion, seizures
• Low glucose
• Low insulin, low C-peptide (not insulinoma)

Why it’s wrong here: The stem gives a clean SIADH lab pattern and doesn’t suggest hypoglycemia at all.

---

High-Yield Paraneoplastic Syndromes (the ones that keep showing up)

Lung cancer is the paraneoplastic king

A few other ultra-testable ones

• Renal cell carcinoma → EPO (polycythemia), renin (HTN)
• Ovarian tumors / hydatidiform mole → $\beta$-hCG (hyperthyroidism, theca-lutein cysts)
• Trousseau syndrome (migratory thrombophlebitis) → pancreatic adenocarcinoma and other mucin-producing adenocarcinomas
• Acanthosis nigricans (sudden onset, extensive) → gastric adenocarcinoma (can also be benign with insulin resistance—watch the context)

---

The “Every Answer Choice Matters” Takeaway

When a question is about paraneoplastic syndromes, you’re being tested on two layers at once:

1. Identify the physiologic pattern (here: SIADH = low serum osmolality + inappropriately high urine osmolality in an euvolemic patient).
2. Map pattern → malignancy and reject distractors by knowing their signature presentation (LEMS weakness pattern, PTHrP hypercalcemia labs, IGF-2 hypoglycemia).

If you train yourself to quickly attach each answer choice to a mini-vignette you could recognize, you’ll stop “pattern matching blindly” and start scoring points on questions designed to punish superficial recall.